Enanta Pharmaceuticals Company
Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective. Enanta Pharmaceuticals has announced its plans to develop antiviral drug candidates to treat COVID-19 patients. The company is testing compounds from its existing antiviral compound library for potential efficacy in treating COVID-19. It has also launched a drug discovery programme to develop direct-acting drug candidates to treat COVID-19.